Related Experiment Video

Updated: May 12, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

Dynamic ecosystems of tumor drug resistance mechanisms: from molecular heterogeneity to systemic interventions

Qiaohong Bao1, Hang Chen2, Jiali Wu1

  • 1Fujian University of Traditional Chinese Medicine, No. 1 Qiuyang Road, Fuzhou, 350122, China.

Apoptosis : an International Journal on Programmed Cell Death
|May 11, 2026
PubMed

Insights

Tumor drug resistance is a complex challenge in cancer treatment. This study introduces a new "Dynamic Ecosystem of Tumor Resistance" framework to understand resistance mechanisms across tumor cells, microenvironment, and host factors.

Area of Science:

  • Oncology
  • Cancer Biology
  • Translational Medicine

Background:

  • Tumor drug resistance significantly hinders cancer treatment efficacy.
  • Current research often overlooks the complex interplay between tumor cells, their microenvironment, and the host system.
  • Understanding these interactions is crucial for overcoming treatment failures.

Purpose of the Study:

  • To propose a novel theoretical framework, the "Dynamic Ecosystem of Tumor Resistance."
  • To integrate intrinsic tumor cell heterogeneity, microenvironment interactions, and host systemic factors.
  • To systematically explore and elucidate key resistance mechanisms and their dynamic interactions.

Main Methods:

  • Development of a multi-level theoretical framework integrating cellular, microenvironmental, and host factors.
  • Systematic analysis of dynamic interactions within the proposed ecosystem.
  • Focus on adaptive evolution and heterogeneity in tumor resistance.

Main Results:

  • Identified the limitations of single-level research in understanding tumor resistance.
  • Proposed a comprehensive framework that accounts for the dynamic ecosystem of tumor resistance.
  • Highlighted the importance of inter-level interactions in driving resistance.

Conclusions:

  • The "Dynamic Ecosystem of Tumor Resistance" framework offers a holistic approach to understanding cancer drug resistance.
  • This framework can guide the development of novel therapeutic strategies targeting resistance.
  • Further research is needed to validate and apply this framework in clinical settings for improved cancer treatment.
Keywords:
Clonal evolutionDynamic ecosystemsEpigenetic reprogrammingHost metabolismTumor drug resistanceTumor microenvironment

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...